Quoin Pharmaceuticals Valuation
| QNRX Stock | USD 0.32 0.01 3.03% |
Quoin Pharmaceuticals seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Quoin Pharmaceuticals from analyzing the company fundamentals such as Return On Equity of -1.35, shares outstanding of 8.19 M, and Shares Owned By Institutions of 18.89 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Quoin Pharmaceuticals' valuation include:
Overvalued
Today
Please note that Quoin Pharmaceuticals' price fluctuation is out of control at this time. Calculation of the real value of Quoin Pharmaceuticals is based on 3 months time horizon. Increasing Quoin Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Quoin Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Quoin Stock. However, Quoin Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.32 | Real 0.31 | Target 4.5 | Hype 0.32 | Naive 0.46 |
The intrinsic value of Quoin Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Quoin Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Quoin Pharmaceuticals Ltd helps investors to forecast how Quoin stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Quoin Pharmaceuticals more accurately as focusing exclusively on Quoin Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Quoin Pharmaceuticals' intrinsic value based on its ongoing forecasts of Quoin Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Quoin Pharmaceuticals' closest peers.
Quoin Pharmaceuticals Cash |
|
Quoin Valuation Trend
Analysing the historical paterns of Quoin Pharmaceuticals' enterprise value and its market capitalization is a good way to estimate and gauge the value of Quoin Pharmaceuticals Ltd over time and is usually enough for investors to make rational market timing decisions.
Quoin Pharmaceuticals Total Value Analysis
Quoin Pharmaceuticals Ltd is at this time projected to have valuation of (7.73 M) with market capitalization of 2.54 M, debt of 3.52 K, and cash on hands of 2.69 M. The negative valuation of Quoin Pharmaceuticals may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Quoin Pharmaceuticals fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(7.73 M) | 2.54 M | 3.52 K | 2.69 M |
Quoin Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Quoin is to check how much profit was generated for every dollar of assets it reports. Quoin Pharmaceuticals holds a negative application of assets of -0.44 pct., losing $0.004413 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Quoin Pharmaceuticals Ltd shows how discouraging it operates for each dollar spent on its assets.Quoin Pharmaceuticals Ownership Allocation
Quoin Pharmaceuticals holds 16.8 pct. of its outstanding shares held by insiders and 18.89 pct. owned by third-party entities.Quoin Pharmaceuticals Profitability Analysis
Net Loss for the year was (8.69 M) with profit before overhead, payroll, taxes, and interest of 0.About Quoin Pharmaceuticals Valuation
Our relative valuation model uses a comparative analysis of Quoin Pharmaceuticals. We calculate exposure to Quoin Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Quoin Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -119 K | -124.9 K | |
| Pretax Profit Margin | (49.23) | (51.69) | |
| Operating Profit Margin | (49.23) | (51.69) | |
| Net Loss | (49.23) | (51.69) | |
| Gross Profit Margin | 1.30 | 1.10 |
Quoin Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 901.1 K |
Quoin Pharmaceuticals Current Valuation Indicators
Valuation refers to the process of determining the present value of Quoin Pharmaceuticals Ltd and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Quoin we look at many different elements of the entity such as Quoin's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Quoin Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Quoin Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Quoin Pharmaceuticals' worth.Additional Tools for Quoin Stock Analysis
When running Quoin Pharmaceuticals' price analysis, check to measure Quoin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quoin Pharmaceuticals is operating at the current time. Most of Quoin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Quoin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quoin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Quoin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.